Robotic Low Anterior Resection in a Narrow Male Pelvis
A 58-year-old obese man (BMI 36) with a mid-rectal T2N0 adenocarcinoma after neoadjuvant chemoradiation has a narrow, deep pelvis on MRI. The surgeon is deciding between laparoscopic and robotic low anterior resection. The laparoscopic approach in this pelvis has historically been difficult for him, with conversion in similar cases. The patient asks about the difference and whether 'the robot' is safer. Hospital resources allow either approach with appropriate scheduling.
1. How do you choose the approach, and what does the evidence actually support?
Read the worked answer
The decision is about the surgeon's demonstrated proficiency and the patient's anatomy, not marketing.
Evidence:
- Randomized and registry data (e.g., ROLARR and subsequent trials) show robotic and laparoscopic rectal resection have comparable oncologic and short-term outcomes overall, with the robotic approach associated with lower conversion rates in some analyses and longer operative times.
- The advantage of robotics is most plausible in the narrow, obese male pelvis, where articulation and visualization help.
Judgment:
- If the surgeon's laparoscopic conversion rate in comparable pelves is high, robotic assistance is a reasonable choice - provided the surgeon has completed the learning curve for robotic rectal surgery.
- The patient should be told that 'safer' is not established; the goal is an equivalent oncologic resection with acceptable morbidity.
Document the rationale and the proficiency basis.
2. What quality metrics should be tracked for this operation regardless of platform?
Read the worked answer
Track process and outcome metrics:
- Oncologic: complete mesorectal excision (TME) grade, circumferential resection margin status, lymph node yield, distal margin.
- Technical: conversion rate, operative time, anastomotic leak rate, blood loss.
- Functional: bowel, urinary, and sexual function at follow-up.
- Process: adherence to ERAS, 30-day readmission, reoperation.
These metrics apply equally to laparoscopic and robotic cases and allow fair comparison. Review them at morbidity and mortality conference.